PT Hetzer Medical Indonesia Tbk (ISX:MEDS) Research & Development: Rp Mil (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:MEDS PT Hetzer Medical Indonesia Tbk ISX:MEDS
21 GF Score
Price Rp82.00
! 2 Warning Signs
View Full Analysis

What is PT Hetzer Medical Indonesia Tbk Research & Development?

PT Hetzer Medical Indonesia Tbk ISX:MEDS +1.23% 21 Research & Development is Rp Mil as of . 20. GuruFocus rates ISX:MEDS with a GF Score™ of 21/100. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. PT Hetzer Medical Indonesia Tbk's Research & Development for the six months ended in . 20 was Rp0.00 Mil. PT Hetzer Medical Indonesia Tbk does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.

PT Hetzer Medical Indonesia Tbk  (ISX:MEDS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

PT Hetzer Medical Indonesia Tbk Research & Development Related Terms

PT Hetzer Medical Indonesia Tbk Research & Development Historical Data

* Premium members only.

The historical data trend for PT Hetzer Medical Indonesia Tbk's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Hetzer Medical Indonesia Tbk Research & Development Chart

PT Hetzer Medical Indonesia Tbk Annual Data
Trend
Research & Development

PT Hetzer Medical Indonesia Tbk Semi-Annual Data
Research & Development
ISX:MEDS
21GF Score
PT Hetzer Medical Indonesia Tbk ISX:MEDS
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Hetzer Medical Indonesia Tbk Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of Rp Mil mean?
PT Hetzer Medical Indonesia Tbk (ISX:MEDS) has a Research & Development of Rp Mil as of . 20. Research and development expense is the total cost for research and development activities. View historical data on PT Hetzer Medical Indonesia Tbk and its competitors.
Is PT Hetzer Medical Indonesia Tbk's Research & Development too high?
PT Hetzer Medical Indonesia Tbk's current Research & Development is Rp Mil. Overall, PT Hetzer Medical Indonesia Tbk has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does PT Hetzer Medical Indonesia Tbk's Research & Development compare to ISRG and BDX?
PT Hetzer Medical Indonesia Tbk's Research & Development of Rp Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on PT Hetzer Medical Indonesia Tbk and its competitors. PT Hetzer Medical Indonesia Tbk's current Research & Development is Rp Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Hetzer Medical Indonesia Tbk stock overvalued right now?
PT Hetzer Medical Indonesia Tbk (ISX:MEDS) has a current Research & Development of Rp Mil. The current Research & Development is Rp Mil. PT Hetzer Medical Indonesia Tbk's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For PT Hetzer Medical Indonesia Tbk (ISX:MEDS), the current Research & Development is Rp Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Hetzer Medical Indonesia Tbk Business Description

Address Jl. Mahar Martanegara No. 106, Kel. Cigugur Tengah, Kec. Cimahi Tengah, Provinsi Jawa Barat, Kota Cimahi, IDN, 40522
PT Hetzer Medical Indonesia Tbk is a pioneer in Indonesia which produces 4 Dimensional Ear Loop type health masks with the trademark Evo Plusmed.
21GF Score

Get the complete analysis for ISX:MEDS

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp82.00
Price